- Home
- RLAY vs NPKI Comparison
RLAY vs NPKI Comparison
Compare RLAY & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | NPKI |
|---|---|---|
| Founded | 2015 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 973.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | NPKI |
|---|---|---|
| Price | $7.82 | $12.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $16.00 | $14.17 |
| AVG Volume (30 Days) | ★ 2.3M | 912.5K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $8,355,000.00 | ★ $259,372,000.00 |
| Revenue This Year | $27.30 | $21.14 |
| Revenue Next Year | $7.43 | $9.42 |
| P/E Ratio | ★ N/A | $32.40 |
| Revenue Growth | N/A | ★ 25.65 |
| 52 Week Low | $1.78 | $4.76 |
| 52 Week High | $8.36 | $14.00 |
Technical Indicators
Market Signals| Indicator | RLAY | NPKI |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 53.63 |
| Support Level | $6.28 | $11.17 |
| Resistance Level | $8.36 | $12.29 |
| Average True Range (ATR) | 0.50 | 0.49 |
| MACD | 0.14 | -0.03 |
| Stochastic Oscillator | 76.56 | 69.35 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.